NCT06457568 Validation Study of CONTEC08C Electronic Sphygmomanometer
| NCT ID | NCT06457568 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese Academy of Medical Sciences, Fuwai Hospital |
| Condition | Blood Pressure |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-05-25 |
| Primary Completion | 2024-07-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2024-05-25 with a primary completion date of 2024-07-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to assess the accuracy of the CONTEC08C automated oscillometric upper-arm sphygmomanometer in the general population for clinical use according to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension /International Organization for Standardization (AAMI/ESH/ISO) Universal Standard (ISO 81060-2:2018).
Eligibility Criteria
Inclusion Criteria: * Subjects aged 12 to 79 years * Subjects voluntarily participate in the clinical trial and sign the informed consent. Exclusion Criteria: * Subjects with cardiac arrhythmias; * Pregnancy; * Poor quality Korotkoff sounds; * Subject with an arm injury incompatible with the use of a cuff-based sphygmomanometer; * Other conditions that the investigator considers ineligible for clinical trial.
Contact & Investigator
Ying Lou, MD
PRINCIPAL INVESTIGATOR
Chinese Academy of Medical Sciences, Fuwai Hospital
Frequently Asked Questions
Who can join the NCT06457568 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 79 Years, studying Blood Pressure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06457568 currently recruiting?
Yes, NCT06457568 is actively recruiting participants. Contact the research team at fuwailou1798@sina.com for enrollment information.
Where is the NCT06457568 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06457568 clinical trial?
NCT06457568 is sponsored by Chinese Academy of Medical Sciences, Fuwai Hospital. The principal investigator is Ying Lou, MD at Chinese Academy of Medical Sciences, Fuwai Hospital. The trial plans to enroll 100 participants.